123 related articles for article (PubMed ID: 8187217)
1. Lp(a) concentrations and phenotypes in children with insulin-dependent diabetes mellitus.
Haffner SM; Frangos M; Williamson J; Santiago J; Valdez R; Aldrete G; Mykkänen L; Gruber KK; Rainwater DL
Chem Phys Lipids; 1994 Jan; 67-68():223-31. PubMed ID: 8187217
[TBL] [Abstract][Full Text] [Related]
2. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
Rudberg S; Persson B
Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
[TBL] [Abstract][Full Text] [Related]
3. Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus.
Klausen IC; Schmidt EB; Lervang HH; Gerdes LU; Ditzel J; Faergeman O
Eur J Clin Invest; 1992 Aug; 22(8):538-41. PubMed ID: 1425859
[TBL] [Abstract][Full Text] [Related]
4. Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects.
Haffner SM; Tuttle KR; Rainwater DL
Diabetes Care; 1991 Apr; 14(4):302-7. PubMed ID: 1829405
[TBL] [Abstract][Full Text] [Related]
5. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
[TBL] [Abstract][Full Text] [Related]
6. Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival?
Kronenberg F; Auinger M; Trenkwalder E; Irsigler K; Utermann G; Dieplinger H
Diabetologia; 1999 Aug; 42(8):1021-7. PubMed ID: 10491765
[TBL] [Abstract][Full Text] [Related]
7. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
Willems D; Dorchy H; Dufrasne D
Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) levels in black and white children and adolescents with IDDM.
Levitsky LL; Scanu AM; Gould SH
Diabetes Care; 1991 Apr; 14(4):283-7. PubMed ID: 1829404
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) levels in children and adolescents with diabetes.
Torres-Tamayo M; Zamora-González J; Bravo-Ríos LE; Cardoso-Saldaña G; Mendoza-Morfín F; Posadas-Romero C
Rev Invest Clin; 1997; 49(6):437-43. PubMed ID: 9580280
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
Martinez MT; Ramos O; Carretero N; Calvillán M; Gutierrez-López MD; Cuesta P; Serrano-Ríos M
Diabete Metab; 1994; 20(5):454-7. PubMed ID: 7859892
[TBL] [Abstract][Full Text] [Related]
11. Method-dependent increase in lipoprotein(a) in insulin-dependent diabetes mellitus during pregnancy.
Pekelharing HL; Aalders NL; Visser GH; van Doormaal JJ; Bouma BN; Kleinveld HA; van Rijn HJ
Metabolism; 1995 Dec; 44(12):1606-11. PubMed ID: 8786731
[TBL] [Abstract][Full Text] [Related]
12. Determination of lipoprotein(a) concentrations and apolipoprotein(a) molecular weights in diabetic patients.
Ribault A; Durou MR; Letellier C; Wojcik F; Poirier JY; Ruelland A
Diabetes Metab; 2000 Apr; 26(2):107-12. PubMed ID: 10804324
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
[TBL] [Abstract][Full Text] [Related]
14. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
[TBL] [Abstract][Full Text] [Related]
15. Association of lipoprotein(a) with puberty in IDDM.
Couper JJ; Bates DJ; Cocciolone R; Magarey AM; Boulton TJ; Penfold JL; Ryall RG
Diabetes Care; 1993 Jun; 16(6):869-73. PubMed ID: 8325200
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.
Clodi M; Oberbauer R; Bodlaj G; Hofmann J; Maurer G; Kostner K
Metabolism; 1999 Mar; 48(3):369-72. PubMed ID: 10094115
[TBL] [Abstract][Full Text] [Related]
18. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
Rainwater DL; MacCluer JW; Stern MP; VandeBerg JL; Haffner SM
Diabetes; 1994 Jul; 43(7):942-6. PubMed ID: 8013760
[TBL] [Abstract][Full Text] [Related]
19. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.
Purnell JQ; Marcovina SM; Hokanson JE; Kennedy H; Cleary PA; Steffes MW; Brunzell JD
Diabetes; 1995 Oct; 44(10):1218-26. PubMed ID: 7556961
[TBL] [Abstract][Full Text] [Related]
20. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus.
Labudovic DD; Toseska KN; Alabakovska SB; B Todorova B
Clin Biochem; 2003 Oct; 36(7):545-51. PubMed ID: 14563448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
